9-(2,3-dihydroxypropyl)adenine has been researched along with pyrimidin-2-one beta-ribofuranoside in 1 studies
| Studies (9-(2,3-dihydroxypropyl)adenine) | Trials (9-(2,3-dihydroxypropyl)adenine) | Recent Studies (post-2010) (9-(2,3-dihydroxypropyl)adenine) | Studies (pyrimidin-2-one beta-ribofuranoside) | Trials (pyrimidin-2-one beta-ribofuranoside) | Recent Studies (post-2010) (pyrimidin-2-one beta-ribofuranoside) |
|---|---|---|---|---|---|
| 56 | 0 | 10 | 207 | 0 | 124 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bittová, M; Fajkus, J; Fojtová, M; Majerová, E; Mozgová, I | 1 |
1 other study(ies) available for 9-(2,3-dihydroxypropyl)adenine and pyrimidin-2-one beta-ribofuranoside
| Article | Year |
|---|---|
Hypomethylating drugs efficiently decrease cytosine methylation in telomeric DNA and activate telomerase without affecting telomere lengths in tobacco cells.
Topics: Adenine; Cells, Cultured; Cytidine; DNA Methylation; DNA, Plant; Enzyme Activation; Epigenesis, Genetic; Nicotiana; Nucleosomes; Plant Proteins; Telomerase; Telomere; Transcription, Genetic | 2011 |